Trial intelligence / Profile preview

Pre-hospital Fibrinogen Concentrate in Trauma Patients (FGTW)

DRKS00005234Phase 2Recruiting

Sponsor
Medical University of Innsbruck
Start
Sep 2013
Modality
Recombinant Proteins and Enzymes
Countries
2
01

Overview

Phase 2, randomised, double-blind trial in hemorrhagic shock and Bleeding comparing Fibrinogen concentrate with Placebo (2 arms). Started Sep 2013; status: recruiting.

02

Drugs

Fibrinogen human
03

Conditions

hemorrhagic shockBleeding

Beyond the preview

Go deeper on DRKS00005234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00005234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call